Article

Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties.

Nutritional Physiology Research Centre, University of South Australia, Australia.
Journal of Child Health Care (Impact Factor: 0.97). 08/2011; 15(4):299-311. DOI: 10.1177/1367493511403953
Source: PubMed

ABSTRACT Suboptimal omega-3 polyunsaturated fatty acid (n-3 PUFA) levels may contribute to attention deficit hyperactivity disorder (ADHD) and related developmental problems. Associations between n-3 and omega-6 (n-6) PUFA levels in red blood cells (erythrocytes) and learning and behaviour were investigated in 75 children aged 7-12 with ADHD. Children provided blood samples and underwent cognitive assessments. Parents completed questionnaires and Conners' Rating Scales. Controlling for covariates, higher n-3 PUFA predicted lower anxiety/shyness (β = -.27), higher docosahexaenoic acid (DHA) better word reading (β = .22), and higher n-6 PUFA poorer reading (β = -.34), vocabulary (β = .-.26), spelling (β = -.30) and attention (β = -.30). Thirty-six per cent of the sample with learning difficulties had lower DHA than those without (M = 3.26 ± 0.54 vs M = 3.68 ± 0.76, p = .02). This study is the first to compare erythrocyte PUFAs (a measure of PUFA status) in children who have ADHD with and without learning difficulties, and supports emerging indications that the former may be more likely responders to n-3 PUFAs.

0 Bookmarks
 · 
88 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of childhood neurodevelopmental disorders, which include autism, attention deficit hyperactivity disorders, and apraxia, are increasing worldwide and have a profound impact on these individuals’ behaviors, cognitive skills, mood and self-esteem. While the etiology of these disorders are unclear, they often accompany genetic and biochemical abnormalities resulting in cognitive and communication difficulties. Because cognitive and neural development require essential fatty acids (particularly long chain ω-3 fatty acids often lacking in mother’s and children’s diets) during critical growth periods, the potential behavior-modifying effects of these fatty acids as “brain nutrients” has attracted considerable attention. Additionally, there is compelling evidence for increased oxidative stress, altered antioxidant defenses, and neuroinflammation in these children. The purpose of this commentary is to provide a scientific rationale based upon cellular, experimental animal model, observational and clinical intervention studies for incorporating the combination of ω-3 fatty acids and tocotrienol-rich vitamin E as complementary nutritional therapies in children with neurodevelopmental disorders. Should this nutritional combination correct key clinical or biochemical outcomes and/or improve behavioral patterns, it would provide a safe, complementary option for these children.
    Nutrition 01/2013; 30(7-8). DOI:10.1016/j.nut.2013.11.001 · 3.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To determine whether supplementation with the long-chain omega-3 polyunsaturated fatty acids eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) affects behavioral symptoms and cognitive impairments in children 6–12 years of age diagnosed with attention-deficit/hyperactivity disorder (ADHD). Study Design The randomized, double-blind placebo-controlled 16 weeks trial was conducted with 95 children diagnosed with ADHD according to DSM-IV criteria. Behavior was assessed by parents, teachers and investigators using standardized rating scales and questionnaires. Further outcome variables were working memory, speed of information processing and various measures of attention. For a subgroup of 81 participants, erythrocyte membrane fatty acid composition was analyzed before and after the intervention. Results Supplementation with the omega-3 fatty acid mix increased EPA and DHA concentrations in erythrocyte membranes and improved working memory function, but had no effect on other cognitive measures and parent- and teacher-rated behavior in the study population. Improved working memory correlated significantly with increased EPA, DHA and decreased AA (arachidonic acid).
    Prostaglandins Leukotrienes and Essential Fatty Acids 07/2014; DOI:10.1016/j.plefa.2014.04.004 · 1.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Available information on clinical guidelines and review articles is controversial and is insufficient to determine the clinical efficacy of supplementation with omega 3 and omega 6 fatty acids in neurodevelopmental disorders. Additional treatment may be effective for the treatment of these disorders.
    08/2012; 69(4):265-270.

Full-text

Download
21 Downloads
Available from
May 31, 2014

Catherine M Milte